Tumorigenesis is a multistep process involving dysregulated cell growth and metastasis. Considerable evidence implicates a mitogenic action of estrogen in early ovarian carcinogenesis. In contrast, its influence in the metastatic cascade of ovarian tumor cells remains obscure. In the present study, we showed that 17β-estradiol (E2) increased the metastatic potential of human epithelial ovarian cancer cell lines. E2 treatment led to clear morphological changes characteristic of epithelial-mesenchymal transition (EMT) and an enhanced cell migratory propensity. These morphological and functional alterations were associated with changes in the abundance of EMT-related genes. Upon E2 stimulation, expression and promoter activity of the epithelia...
The notion that menopausal estrogen replacement therapy increases ovarian cancer risk, but only for ...
AbstractA recent paper in Cell (Fujita et al., 2003) demonstrates that MTA3, a novel component of th...
BACKGROUND: Snail, a transcriptional factor and repressor of E-cadherin is well known for its role i...
Benign ovarian tumors and majority of epithelial ovarian cancers possess steroid receptors including...
Objective.: The transcription factor Snail, which is implicated in the triggering of epithelial-mese...
Estrogens regulate normal ovarian surface epithelium (OSE) cell functions but also affect epithelial...
Abstract Estrogen is a steroid hormone that has critical roles in reproductive development, bone hom...
The estrogen receptor (ER) is expressed in approximately 70% of sporadic breast cancers and is belie...
Epithelial-mesenchymal transition (EMT) serves as a key mechanism driving tumour cell migration, inv...
Estrogens are steroid hormones produced by the ovaries and extra ovarian tissues including the adren...
<div><p>Ovarian cancer is the gynecological cancer exhibiting the highest morbidity and improvement ...
Ovarian cancer is the gynecological cancer exhibiting the highest morbidity and improvement of treat...
Abstract Background The epithelial to mesenchymal tra...
The overexpression of epidermal growth factor receptor (EGFR) has been shown in ovarian cancer and i...
E-cadherin is a membrane glycoprotein located at cell adherens junctions. A switch from E-cadherin t...
The notion that menopausal estrogen replacement therapy increases ovarian cancer risk, but only for ...
AbstractA recent paper in Cell (Fujita et al., 2003) demonstrates that MTA3, a novel component of th...
BACKGROUND: Snail, a transcriptional factor and repressor of E-cadherin is well known for its role i...
Benign ovarian tumors and majority of epithelial ovarian cancers possess steroid receptors including...
Objective.: The transcription factor Snail, which is implicated in the triggering of epithelial-mese...
Estrogens regulate normal ovarian surface epithelium (OSE) cell functions but also affect epithelial...
Abstract Estrogen is a steroid hormone that has critical roles in reproductive development, bone hom...
The estrogen receptor (ER) is expressed in approximately 70% of sporadic breast cancers and is belie...
Epithelial-mesenchymal transition (EMT) serves as a key mechanism driving tumour cell migration, inv...
Estrogens are steroid hormones produced by the ovaries and extra ovarian tissues including the adren...
<div><p>Ovarian cancer is the gynecological cancer exhibiting the highest morbidity and improvement ...
Ovarian cancer is the gynecological cancer exhibiting the highest morbidity and improvement of treat...
Abstract Background The epithelial to mesenchymal tra...
The overexpression of epidermal growth factor receptor (EGFR) has been shown in ovarian cancer and i...
E-cadherin is a membrane glycoprotein located at cell adherens junctions. A switch from E-cadherin t...
The notion that menopausal estrogen replacement therapy increases ovarian cancer risk, but only for ...
AbstractA recent paper in Cell (Fujita et al., 2003) demonstrates that MTA3, a novel component of th...
BACKGROUND: Snail, a transcriptional factor and repressor of E-cadherin is well known for its role i...